New contract in Belgium with Byteflies – Medicalgorithmics achieves record number of AI-powered diagnostic agreements
Warsaw Stock Exchange-listed Medicalgorithmics continues its dynamic growth trajectory, capitalizing on unprecedented demand for its proprietary AI-powered diagnostic software. The Polish medtech company has entered into a partnership agreement with IDTF in Belgium – Byteflies. Pursuant to the agreement, the DeepRhythmAI (DRAI) artificial intelligence algorithms – recognized by Nature Medicine – will become available to Byteflies upon completion of integration and receipt of the requisite regulatory approvals. The contract includes guaranteed monthly minimums. This marks the thirteenth new client acquired by Medicalgorithmics in 2025.